When the Disease Is Quiet, It Is Easy to Forget It Is There

A Story About Juvenile Idiopathic Arthritis and the Importance of Long-Term Control

Author's note: The family kindly gave permission for this case to be shared for educational purposes. Although identifying details have been omitted or modified to protect privacy, the clinical journey and lessons described remain true to the case. The events described are this patient's own clinical story; the references cited below relate to general guidance, not to this individual case.

Among the many remarkable advances in modern medicine, few are as encouraging as the change in outlook for children with juvenile idiopathic arthritis (JIA).

Juvenile idiopathic arthritis and associated uveitis can cause substantial joint, functional and visual complications. Modern treatment and structured monitoring have improved disease control for many children, although outcomes and treatment needs vary.¹,²

Yet one challenge remains. The very success of treatment can sometimes make the disease seem as though it has disappeared.

It Began With a Swollen Toe

A four-year-old boy was brought to the clinic after his parents noticed that one of his toes had become swollen and tender. At first, it did not seem particularly alarming. Children injure themselves while playing, and a swollen toe can easily be mistaken for a minor injury.

But over the following months another toe became swollen. Then his eyes became red.

An examination confirmed severe uveitis associated with juvenile idiopathic arthritis. In his case, by the time he first arrived at our clinic, the inflammation had already caused irreversible damage to one eye. Despite every effort, that eye could not be saved.

Our immediate priority became protecting the vision in his remaining eye while bringing both the arthritis and the eye inflammation under control.

Looking Beyond the Joints

Many people are surprised to learn that juvenile idiopathic arthritis is not simply a disease of the joints. Inflammation can also affect the eyes. JIA-associated uveitis may cause few or no symptoms, particularly early in its course. Regular ophthalmic screening is therefore recommended according to the child's risk factors, even when the eyes appear comfortable.²

Fifteen Years of Stability

With appropriate treatment, the inflammation in this child gradually came under control. The remaining eye stayed healthy. His joints improved. He returned to school, sports, and the ordinary experiences of childhood.

For the next fifteen years, his disease remained well controlled.

Success Can Create a New Challenge

Successful treatment can make a chronic disease almost invisible. Children feel well. Parents see a healthy child. It becomes easy to wonder whether treatment is still necessary.

Sometimes a child who feels well has genuinely quiet disease; sometimes the treatment itself is what is keeping the disease quiet. Only clinical assessment, examination and — where relevant — ophthalmic review can tell the difference. This is one of the reasons treatment decisions in rheumatology are made with the long term in mind, not just today's symptoms.

When Life Changes

After many years of stability, his father's employment ended and the family returned to their home country. Like many families facing major life changes, they encountered practical challenges. Access to healthcare changed. Financial considerations became important. His treatment had to be modified outside of a planned clinical review.

Unfortunately, in his case the inflammation returned. This time it affected the remaining eye. Despite every effort to regain control, the damage progressed, and he eventually lost vision in that eye as well.

The Lesson Is Larger Than One Child

Every child with juvenile idiopathic arthritis has a different journey, and this outcome is not what most children with JIA experience. The purpose of this story is not to create fear. It is to illustrate one principle: the absence of symptoms alone is not sufficient evidence that treatment or monitoring is no longer needed.

Decisions to reduce or stop therapy are reasonable to discuss, but they require individualized assessment — of disease control, previous disease course, current medication, any associated uveitis and the risk of recurrence — together with continued monitoring.¹,²

A Partnership That Lasts for Years

Caring for a child with juvenile idiopathic arthritis is a long-term partnership. Rheumatology follow-up and ophthalmic-screening intervals are individualized, based on the child's subtype, treatment and uveitis risk. If you are unsure whether your child's symptoms need specialist review, our guide on when to see a rheumatologist may help.

A Final Thought

One of the greatest gifts modern medicine can offer a child with juvenile idiopathic arthritis is the chance to grow up largely forgetting they have the disease. Paradoxically, that is also the moment when it becomes easiest to underestimate the value of continued review.

Sometimes, the quietest diseases are the ones that deserve the most careful follow-up.

Frequently Asked Questions

Can juvenile arthritis affect the eyes without symptoms?

It can. JIA-associated uveitis may cause few or no symptoms, especially early on, which is why ophthalmic screening is recommended at intervals based on the child's individual risk factors rather than on how the eyes feel.²

If my child has no symptoms, can we stop treatment?

Do not stop or reduce treatment without discussing it with the treating team. Whether treatment can be tapered depends on disease control, previous course, current therapy, associated uveitis and the individual risk of recurrence.¹

How often should a child with JIA be reviewed?

Intervals are individualized. Rheumatology follow-up and ophthalmic screening frequency depend on the JIA subtype, current treatment and uveitis risk factors, and are set by the treating specialists.²

Where can my child be assessed in Dubai?

Dr. Bassel Darwish provides paediatric and adult rheumatology care at Health Call Clinic, Dubai Healthcare City. Book a consultation or call +971 4 363 5343.